U.S. patient with advanced lung cancer stabilized by novel immunotherapy treatment in China
Jiahui International Cancer Center (JICC) stabilized non‑small cell lung cancer (NSCLC) and Parkinson's disease in patient using novel immunotherapy ivonescimab
























